Company: DARE
Filing Date: 2025-05-13
Form Type: 8-K
Source: 0001641172-25-009939
Chunk: 0

Company: Dare Bioscience, Inc.
Filing Date: 2025-05-13
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item      Results                                 

On
May 13, 2025, Daré Bioscience, Inc. (the “ Company”) issued a press release announcing its financial results for the
quarter ended March 31, 2025, a copy of which is furnished as Exhibit 99.1 to this report.

The
information in this Item 2.02 and in Exhibit 99.1 to this report is being furnished and shall not be deemed to be “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject
to the liabilities of that section, nor shall such information be deemed to be incorporated by reference into any filing under the Exchange
Act or the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation
by reference language in any such filing, except as the Company expressly sets forth by specific reference in such filing.